Background-Arterial stiffening with increased pulse pressure is a leading risk factor for cardiovascular disease in the elderly. We tested whether ALT-711, a novel nonenzymatic breaker of advanced glycation end-product crosslinks, selectively improves arterial compliance and lowers pulse pressure in older individuals with vascular stiffening.Methods and Results-Nine US centers recruited and randomly assigned subjects with resting arterial pulse pressures > 60 mm Hg and systolic pressures > 140 min Hg to once-daily ALT-711 (210 mg; n=62) or placebo (n=31) for 56 days. Preexisting antihypertensive treatment (90% of subjects) was continued during the study. Morning upright blood pressure, stroke volume, cardiac output, systemic vascular resistance, total arterial compliance, carotid-femoral pulse wave velocity, and drug tolerability were assessed. ALT-711 netted a greater decline in pulse pressures than placebo (-5.3 versus -0.6 min Hg at day 56; P=0.034 for treatment effect by repeated-measures ANOVA). Systolic pressure declined in both groups, but diastolic pressure fell less with ALT-711 (P=0.056). Mean pressure declined similarly in both groups (-4 mm Hg; P <0.01 for each group, P=0.34 for treatment effect). Total arterial compliance rose 15% in ALT-711-treated subjects versus no change with placebo (P=0.015 versus ALT-711), an effect that did not depend on reduced mean pressure. Pulse wave velocity declined 8% with ALT-711 (P <0.05 at day 56, P=0.08 for treatment effect). Systemic arterial resistance, cardiac output, and heart rate did not significantly change in either group.Conclusions-ALT-711 improves total arterial compliance in aged humans with vascular stiffening, and it may provide a novel therapeutic approach for this abnormality, which occurs with aging, diabetes, and isolated systolic hypertension.
Improved arterial compliance by a novel advanced glycation end-product crosslink breaker / Kass, Da; Shapiro, Ep; Kawaguchi, M; Capriotti, Ar; Scuteri, A; Degroof, Rc; Lakatta, Eg. - In: CIRCULATION. - ISSN 0009-7322. - 104:13(2001), pp. 1464-1470.
Scheda prodotto non validato
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo
|Titolo:||Improved arterial compliance by a novel advanced glycation end-product crosslink breaker|
|Data di pubblicazione:||2001|
|Citazione:||Improved arterial compliance by a novel advanced glycation end-product crosslink breaker / Kass, Da; Shapiro, Ep; Kawaguchi, M; Capriotti, Ar; Scuteri, A; Degroof, Rc; Lakatta, Eg. - In: CIRCULATION. - ISSN 0009-7322. - 104:13(2001), pp. 1464-1470.|
|Appare nelle tipologie:||1.1 Articolo in rivista|